COVID19 s-vax loaded autologous dendritic cell vaccine

COVID19 s-vax loaded autologous dendritic cell vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

Dendritic cells (DCs) can be derived and differentiated from peripheral blood mononuclear cells in the presence of specific cytokines and growth factors. These cells are then loaded with antigens produced by a virus or tumor cell and administered as a vaccine.

Dendritic Cells (DCs) are showing potential as natural adjuvants for vaccines due to their ability to both prime and boost cell responses; they are considered the most powerful antigen-presenting cells, and are able to present antigens through costimulatory signals required for activation of CD4+ and CD8+ T-cells. DC-based vaccines are currently used in cancer therapeutics, and are being tested for COVID-19. The rationale is that loading a DC cell with SARS-Cov-2 antigens and administering it as a vaccine can induce a more prolific immune response.

This vaccine was developed and tested by Beijing TIL Therapeutics. As of May 2020, the company is pursuing a human clinical trial (ChiCTR2000033003) to test the safety and immunogenicity of the vaccine.

Trade Name COVID19 s-vax loaded autologous dendritic cell vaccine
Generic COVID19 s-vax loaded autologous dendritic cell vaccine
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
COVID19 s-vax loaded autologous dendritic cell vaccine
COVID19 s-vax loaded autologous dendritic cell vaccine

Innovators Monograph

You find simplified version here COVID19 s-vax loaded autologous dendritic cell vaccine


*** Taking medicines without doctor's advice can cause long-term problems.
Share